- Report
- September 2024
- 100 Pages
Global
From €5250EUR$5,950USD£4,541GBP
- Report
- April 2025
- 141 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- August 2025
- 193 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 185 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- September 2025
- 254 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- May 2025
- 120 Pages
Global
From €4191EUR$4,750USD£3,625GBP
- Report
- February 2025
- 150 Pages
Global
From €2788EUR$3,160USD£2,412GBP
€3485EUR$3,950USD£3,014GBP
- Report
- August 2025
- 189 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- May 2025
- 120 Pages
Global
From €5250EUR$5,950USD£4,541GBP
- Report
- January 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- August 2025
- 186 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 181 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 182 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 187 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 196 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 197 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- September 2025
- 372 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 371 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 374 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 300 Pages
Global
From €5162EUR$5,850USD£4,465GBP

The Infection Surveillance Solutions market is a subset of the Infectious Disease Testing market, focusing on the development of solutions to monitor and track the spread of infectious diseases. These solutions are designed to provide healthcare professionals with the data and insights they need to identify and respond to potential outbreaks. Solutions may include software, hardware, and services that enable the collection, analysis, and sharing of data related to infectious diseases.
The Infection Surveillance Solutions market is driven by the need to improve public health outcomes and reduce the economic impact of infectious diseases. Governments, healthcare providers, and other stakeholders are increasingly investing in solutions to better understand and respond to the spread of infectious diseases.
Companies in the Infection Surveillance Solutions market include IBM, Epic Systems, Cerner Corporation, Allscripts, and Athenahealth. Show Less Read more